225 related articles for article (PubMed ID: 22825304)
21. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.
Jung SM; Moon SJ; Kwok SK; Ju JH; Park KS; Park SH; Kim HY
Lupus; 2013 Aug; 22(9):885-91. PubMed ID: 23846231
[TBL] [Abstract][Full Text] [Related]
22. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.
Gatla N; Annapureddy N; Sequeira W; Jolly M
J Clin Rheumatol; 2013 Sep; 19(6):334-40. PubMed ID: 23965484
[TBL] [Abstract][Full Text] [Related]
23. MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus.
Muscal E; Traipe E; de Guzman MM; Myones BL; Brey RL; Hunter JV
Pediatr Radiol; 2010 Jul; 40(7):1241-5. PubMed ID: 20119723
[TBL] [Abstract][Full Text] [Related]
24. Posterior reversible encephalopathy syndrome in juvenile lupus- a case series and literature review.
Baisya R; Kumar Devarasetti P; Narayanan R; Rajasekhar L
Lupus; 2022 Apr; 31(5):606-612. PubMed ID: 35337220
[TBL] [Abstract][Full Text] [Related]
25. [Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case report].
Zhang XH; Deng XR; Li F; Zhu Y; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1102-1107. PubMed ID: 30562790
[TBL] [Abstract][Full Text] [Related]
26. Posterior reversible encephalopathy syndrome as an initial manifestation of systemic lupus erythematosus.
Ayas ÖZ; Öcal RÖ; Gundogdu AA
Ideggyogy Sz; 2017 Nov; 70(11-12):425-427. PubMed ID: 29870651
[TBL] [Abstract][Full Text] [Related]
27. Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides.
Marra AM; Barilaro G; Villella V; Granata M
Rheumatol Int; 2015 Sep; 35(9):1591-5. PubMed ID: 25836767
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study.
Merayo-Chalico J; Apodaca E; Barrera-Vargas A; Alcocer-Varela J; Colunga-Pedraza I; González-Patiño A; Arauz A; Abud-Mendoza C; Martínez-Martínez M; Gómez-Martín D
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):287-94. PubMed ID: 25804426
[TBL] [Abstract][Full Text] [Related]
29. Post reversible encephalopathy syndrome attributed to mycophenolate mofetil used in the treatment of SLE: A case report and review of literature.
Dai Y; Liu W; Hong F
J Int Med Res; 2024 Jan; 52(1):3000605231218620. PubMed ID: 38156668
[TBL] [Abstract][Full Text] [Related]
30. Central-variant posterior reversible encephalopathy syndrome in a young patient with systemic lupus erythematosus.
Maier S; Monica C; Romaniuc A; Andone S; Bălaşa R
Acta Neurol Belg; 2019 Jun; 119(2):269-271. PubMed ID: 30467758
[No Abstract] [Full Text] [Related]
31. Posterior Reversible Encephalopathy Syndrome: A Rare Childhood Case with Unconsciousness.
Komori A; Mizu D; Ariyoshi K
J Emerg Med; 2018 Apr; 54(4):540-543. PubMed ID: 29338905
[TBL] [Abstract][Full Text] [Related]
32. The challenging clinical dilemma of posterior reversible encephalopathy syndrome in systemic lupus erythematosus.
Liu Y; Li Q; Liu Y; Qiao P; Liu S; Xu K
Z Rheumatol; 2024 Feb; 83(Suppl 1):124-131. PubMed ID: 37405426
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus.
Lai CC; Chen WS; Chang YS; Wang SH; Huang CJ; Guo WY; Yang WC; Huang DF
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1766-74. PubMed ID: 23687067
[TBL] [Abstract][Full Text] [Related]
34. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature reviews and report of six new cases.
Shaharir SS; Remli R; Marwan AA; Said MS; Kong NC
Lupus; 2013 Apr; 22(5):492-6. PubMed ID: 23435619
[TBL] [Abstract][Full Text] [Related]
35. The Association of Hypertension With Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus Patients: A Systematic Review.
Bhangu JK; Javed K; Manshahia PK; Nahar S; Kanda S; Chatha U; Odoma VA; Pitliya A; AlEdani EM; Khan S
Cureus; 2023 Dec; 15(12):e50620. PubMed ID: 38226131
[TBL] [Abstract][Full Text] [Related]
36. Therapy and differential diagnosis of posterior reversible encephalopathy syndrome (PRES) during pregnancy and postpartum.
Cozzolino M; Bianchi C; Mariani G; Marchi L; Fambrini M; Mecacci F
Arch Gynecol Obstet; 2015 Dec; 292(6):1217-23. PubMed ID: 26122264
[TBL] [Abstract][Full Text] [Related]
37. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature.
Motolese F; Ferrante M; Rossi M; Magliozzi A; Sbarra M; Ursini F; Marano M; Capone F; Travaglino F; Antonelli Incalzi R; Di Lazzaro V; Pilato F
J Neurol; 2021 Dec; 268(12):4407-4414. PubMed ID: 34291313
[TBL] [Abstract][Full Text] [Related]
38. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.
Varaprasad IR; Agrawal S; Prabu VN; Rajasekhar L; Kanikannan MA; Narsimulu G
J Rheumatol; 2011 Aug; 38(8):1607-11. PubMed ID: 21572160
[TBL] [Abstract][Full Text] [Related]
39. Posterior reversible encephalopathy syndrome and autoimmunity.
Li Y; Song J; Huq AM; Timilsina S; Gershwin ME
Autoimmun Rev; 2023 Feb; 22(2):103239. PubMed ID: 36464226
[TBL] [Abstract][Full Text] [Related]
40. Posterior reversible encephalopathy syndrome in children with kidney disease.
Gavrilovici C; Miron I; Voroneanu L; Bădărau S; Stârcea M
Int Urol Nephrol; 2017 Oct; 49(10):1793-1800. PubMed ID: 28836059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
